MarginProbe 2.0 Data Collection Protocol

CompletedOBSERVATIONAL
Enrollment

398

Participants

Timeline

Start Date

December 15, 2021

Primary Completion Date

August 23, 2024

Study Completion Date

January 12, 2025

Conditions
Breast Cancer
Interventions
DEVICE

MarginProbe2.0

The MarginProbe System is an adjunctive diagnostic tool for identification of cancerous tissue at the margins of the ex-vivo lumpectomy specimen following primary excision and is indicated for intraoperative use, in conjunction with standard methods (such as intraoperative imaging and palpation) in patients undergoing breast lumpectomy surgery for previously diagnosed breast cancer.

Trial Locations (9)

10305

Northwell Health, Staten Island

10549

Northwell Northern Westchester, Mount Kisco

11203

Health and Hospitals Corporation/Kings County, Brooklyn

18017

Lehigh Valley, Bethlehem

52403

Mercy Medical Center, Cedar Rapids

59901

Logan Health Breast Center, Kalispell

91120

Hadassah Medical Organization, Jerusalem

91206

Glendale Adventist Medical Center, Glendale

07631

Englewood Health, Englewood

All Listed Sponsors
lead

Dilon Medical Technologies Ltd.

INDUSTRY

NCT05377229 - MarginProbe 2.0 Data Collection Protocol | Biotech Hunter | Biotech Hunter